These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27743567)

  • 1. Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.
    Agostini A; Kircher MF; Do R; Borgheresi A; Monti S; Giovagnoni A; Mannelli L
    Semin Roentgenol; 2016 Oct; 51(4):308-316. PubMed ID: 27743567
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of magnetic resonance imaging contrast agents in the liver and biliary tract.
    Lebedis C; Luna A; Soto JA
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
    Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
    Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical use and pitfalls of hepatocyte-specific contrast agents (HSCAs) for pediatric hepatic and biliary magnetic resonance imaging.
    Ayyala RS; Anupindi SA; Callahan MJ
    Abdom Radiol (NY); 2017 Feb; 42(2):502-520. PubMed ID: 27680015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions.
    Agostini A; Kircher MF; Do RK; Borgheresi A; Monti S; Giovagnoni A; Mannelli L
    Semin Roentgenol; 2016 Oct; 51(4):317-333. PubMed ID: 27743568
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance contrast agents for liver imaging.
    Bashir MR
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):283-93. PubMed ID: 25086930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion and perfusion imaging of the liver.
    Chandarana H; Taouli B
    Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR contrast agents for liver imaging: what, when, how.
    Gandhi SN; Brown MA; Wong JG; Aguirre DA; Sirlin CB
    Radiographics; 2006; 26(6):1621-36. PubMed ID: 17102040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI of the liver--how to do it.
    Vasanawala SS
    Pediatr Radiol; 2010 Apr; 40(4):431-7. PubMed ID: 20225098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast volumetric data acquisition in abdominal computed tomography and magnetic resonance imaging.
    Van Hoe L
    J Belge Radiol; 1997 Oct; 80(5):258. PubMed ID: 9400062
    [No Abstract]   [Full Text] [Related]  

  • 12. Magnetic resonance imaging of the liver.
    Vassiliades VC; Bernardino ME
    Top Magn Reson Imaging; 1990 Jun; 2(3):1-16. PubMed ID: 2161245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
    Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
    Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Function Assessment by Magnetic Resonance Imaging.
    Ünal E; Akata D; Karcaaltincaba M
    Semin Ultrasound CT MR; 2016 Dec; 37(6):549-560. PubMed ID: 27986173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
    Burke C; Alexander Grant L; Goh V; Griffin N
    Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced ultrasound of the liver and kidney.
    Malhi H; Grant EG; Duddalwar V
    Radiol Clin North Am; 2014 Nov; 52(6):1177-90. PubMed ID: 25444099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Part 2: MRI of hypervascular focal liver lesions using liver specific contrast agents.
    Sutherland T; Seale M; Yap K
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):56-63. PubMed ID: 24529056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Key to upper abdomen MRI imaging].
    Nogi A
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2006 Jan; 62(1):28-38. PubMed ID: 16485357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.